上海先祥医疗科技披露新型EGFR降解诱导剂
Shanghai Xianxiang Medical Technology divulges new EGFR degradation inducers
生物技术与制药领域的最新动态
Shanghai Xianxiang Medical Technology divulges new EGFR degradation inducers
Laekna Pharmaceutical describes new WRN inhibitors
New NLRP3 inhibitors disclosed in Neushen Therapeutics patent
Shandong Simcere Medgenn Bio-Pharmaceutical discovers new CDK4/cyclin D1 inhibitors
Med-tech gainers and losers for Dec. 15-19, 2025
Financings for Dec. 22, 2025
In the clinic for Dec. 22, 2025
Other news to note for Dec. 22, 2025
Regulatory actions for Dec. 22, 2025
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
Biggest gainers and losers for Dec. 15-19, 2025
Laekna Pharmaceutical divulges new PI3Kα inhibitors
Aché Laboratórios Farmacêuticos describes new SGLT-1, SGLT-2 and DPP4 inhibitors
New TEAD inhibitors disclosed in Signet Therapeutics patent
Jiangsu Simcere Biologics discovers new bispecific ADCs
In the clinic for Dec. 19, 2025
Other news to note for Dec. 19, 2025
Regulatory actions for Dec. 19, 2025
Appointments and advancements for Dec. 19, 2025